With TECH you will discover the latest trends and techniques in the treatment of Multiple Myeloma and Primary Amyloidosis from leading experts in the field"

Multiple Myeloma is a type of cancer that affects plasma cells, while Primary Amyloidosis is a disease in which abnormal proteins accumulate in the body's organs and tissues. These pathologies affect a large number of people worldwide, as they are difficult to treat and can be devastating for both patients and their families. 

For this reason, it is essential to have specialists in Oncohematology who are up to date in the latest advances in the diagnosis and intervention of these diseases. The Postgraduate certificate in Multiple Myeloma and Primary Amyloidosis is designed to provide healthcare professionals with the necessary tools to face these challenges. 

The program focuses on providing students with a comprehensive understanding of the pathophysiology, diagnosis and management of these hematologic disorders. Through a practical and evidence-based approach, they will learn to apply the latest techniques and treatment strategies in the care of patients with these conditions. 

This Postgraduate certificate is taught in a 100% online model, which allows future TECH graduates to study at their own pace and from anywhere. The Relearning pedagogical methodology is used to maximize the efficiency of learning, which allows to consolidate and apply the acquired knowledge immediately. In addition, students have access to innovative didactic material whenever they wish, which gives them the flexibility to organize their academic resources and study at their own pace.

Access the Relearning pedagogical method, which will guarantee you a personalized learning experience, adapted to your pace and learning style"

This Postgraduate certificate in Multiple Myeloma and Primary Amyloidosis contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of case studies presented by experts in Multiple Myeloma and Primary Amyloidosis
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where self-assessment can be used to improve learning 
• Its special emphasis on innovative methodologies 
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection

With TECH you will have the opportunity to access a wide variety of job opportunities in the field of research, teaching or health care" 

The program’s teaching staff includes professionals from sector who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities. 

Its multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersive education programmed to learn in real situations. 

The design of this program focuses on Problem-Based Learning, by means of which the professional must try to solve the different professional practice situations that are presented throughout the academic course. This will be done with the help of an innovative system of interactive videos made by renowned experts.

Obtain quality training in one of the most demanded areas in the health sector and become a highly qualified professional"

Become a leader in the field of Oncohematology, thanks to the skills and competencies you will acquire with this Postgraduate certificate"

The Postgraduate certificate Multiple Myeloma and Primary Amyloidosis provides the student with the most updated content on the treatment of these diseases, including relevant indexes and prognoses. The program delves into the latest scientific evidence related to the specific drugs used throughout the process of intervention in patients. In addition, the innovative didactic material is available 24 hours a day, 7 days a week, allowing for effective and flexible learning.

Looking for a rigorous update in the treatment of complex hematologic diseases? This Postgraduate certificate is the best option for acquiring the skills" 

Module 1. Multiple myeloma and primary amyloidosis

1.1. Monoclonal Gammopathy of Uncertain Significance 
1.1.1. Low- and High- Degrees GMSI 
1.1.2. Recommended evaluations 
1.1.3. GM of renal and other significance 

1.2. Multiple Myeloma (MM) Etiopathogenesis., Diagnosis and Prognosis 

1.2.1. Diagnostic Criteria 
1.2.2. Genetic Alterations 
1.2.3. Prognostic indices 

1.3. Treatment Indications 

1.3.1. WHO Criteria 
1.3.2. Quiescent MM 

1.4. MM First in Line Treatment 

1.4.1. Suitability for TASPE in 1L 
1.4.2. Types of drugs 
1.4.3. Recommended combinations 

1.5. Relapse/refractory treatment 

1.5.1. General Considerations. Treatment Indications 
1.5.2. Available Drugs 
1.5.3. Algorithms or possible sequences 

1.6. New Treatments in MM 

1.6.1. Anti-BCMA antibody conjugates 
1.6.2. Bispecific anti BCMA antibodies 
1.6.3. Others: elotuzumab, selinexor 

1.7. CAR T at mm 

1.7.1. Cilta-cel 
1.7.2. Ide-cel 

1.8. Primary Amyloidosis. Diagnosis and Prognosis 

1.8.1. Etiopathogenesis
1.8.2. Diagnostic 
1.8.3. Prognosis 

1.9. Primary Amyloidosis. Treatment 

1.9.1. AutoTPH role 
1.9.2. Alkylators and proteosome inhibitors 
1.9.3. Role of antiCD38 antibodies 

1.10. Treatment goals in MM/AL 

1.10.1. Methodological limitations in the literature 
1.10.2. Validation of survival surrogate variables

Apply now to run all your skills automatically in the bone marrow cancer medical field"